{
    "organizations": [],
    "uuid": "1404c342bbec36c2f83f8d897a729a3b30e6c56f",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/05/07/the-associated-press-ultragenyx-1q-earnings-snapshot.html",
    "ord_in_thread": 0,
    "title": "Ultragenyx: 1Q Earnings Snapshot",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "NOVATO, Calif. (AP) _ Ultragenyx Pharmaceutical Inc. (RARE) on Monday reported first-quarter net income of $30.3 million, after reporting a loss in the same period a year earlier.\nThe Novato, California-based company said it had profit of 62 cents per share.\nThe results beat Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for a loss of 60 cents per share.\nThe biotechnology company posted revenue of $10.7 million in the period, which did not meet Street forecasts. Ten analysts surveyed by Zacks expected $53.4 million.\nUltragenyx shares have increased 25 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $57.96, a fall of 5 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on RARE at https://www.zacks.com/ap/RARE",
    "published": "2018-05-08T00:26:00.000+03:00",
    "crawled": "2018-05-08T02:22:37.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "novato",
        "ap",
        "ultragenyx",
        "pharmaceutical",
        "rare",
        "monday",
        "reported",
        "net",
        "income",
        "million",
        "reporting",
        "loss",
        "period",
        "year",
        "earlier",
        "novato",
        "company",
        "said",
        "profit",
        "cent",
        "per",
        "share",
        "result",
        "beat",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "biotechnology",
        "company",
        "posted",
        "revenue",
        "million",
        "period",
        "meet",
        "street",
        "forecast",
        "ten",
        "analyst",
        "surveyed",
        "zacks",
        "expected",
        "million",
        "ultragenyx",
        "share",
        "increased",
        "percent",
        "since",
        "beginning",
        "year",
        "final",
        "minute",
        "trading",
        "monday",
        "share",
        "hit",
        "fall",
        "percent",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "rare",
        "http"
    ]
}